Analysis of sentinel lymph node mapping with immediate pathologic review in patients receiving preoperative chemotherapy for breast carcinoma

Annals of Surgical Oncology

Volumn 9, Issue 3, 2002, Pages 243-247

  Miller, Alexander R ^a   Thomason, Virginia E ^a   Yeh, I Tien ^a   Alrahwan, Amin ^a   Sharkey, Francis E ^a   Stauffer, Jay ^a   Otto, Pamela M ^a   McKay, Claire ^a   Kahlenberg, Morton S ^a   Phillips, William T ^a   Cruz Jr , Anatolio B ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Axillary lymph node dissection; Breast cancer; Neoadjuvant chemotherapy; Sentinel lymph node mapping

Indexed keywords

ANTINEOPLASTIC AGENT; ISOSULFAN BLUE; TECHNETIUM SULFUR COLLOID TC 99M;

ADJUVANT CHEMOTHERAPY; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; PREOPERATIVE PERIOD; SENTINEL LYMPH NODE; TREATMENT PLANNING;

EID: 0036214648     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02573061     Document Type: Article

References (32)

1. Technical details of intraoperative lymphatic mapping for early stage melanoma
2. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe
3. Lymphatic mapping and SLNB in the patient with breast cancer
4. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma
5. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma
6. Improved axillary staging of breast cancer with sentinel lymphadenectomy
7. Intraoperative lymphatic mapping and sentinel lymph node dissection in breast carcinoma
8. Incidence and predictors of axillary metastases in T1 carcinoma of the breast
9. Lymphatic mapping and sentinel lymphadenectomy for breast cancer
10. Sentinel lymphadenectomy in breast cancer
11. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes
12. Sentinel node in breast cancer
13. Axillary staging utilizing selective sentinel lymphadenectomy for patients with breast cancer
14. Sentinel lymph node involvement - A predictor for axillary node status with breast cancer-has the time come?
15. Neoadjuvant chemotherapy for breast cancer
16. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18
17. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma
18. Complementarity of blue dye and isotope in sentinel node localization for breast cancer: Univariate and multivariate analysis of 966 procedures
19. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy
20. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer
21. Credentialing for breast lymphatic mapping: How many cases are enough?
22. Intraoperative pathologic evaluation of a breast cancer sentinel lymph node biopsy as a determinant for synchronous axillary lymph node dissection
23. Intraoperative sentinel lymph node examination by imprint cytology and frozen section during breast surgery
24. Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer
25. Is routine intraoperative frozen-section examination of sentinel lymph nodes in breast cancer worthwhile?
26. Sentinel lymph node biopsy in breast cancer: Initial experience at Memorial Sloan-Kettering Cancer Center
27. Detection and significance of occult metastases in node-negative breast cancer
28. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients
29. Occult axillary node metastases in breast cancer: Their detection and prognostic significance
30. The immunocytochemical detection of axillary micrometastases in breast cancer
31. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: Re-evaluation with longer follow-up
32. Residual metastatic axillary lymph node post neoadjuvant chemotherapy predicts disease-free survival in patients with locally advanced breast carcinoma